ALB and diabetes mellitus: It should be noted that in vivo albumin glycation which is increased in in diabetes may have a direct impact on the binding ability towards gliclazide, and subsequently its free drug fraction and pharmacokinetics (Żurawska-Płaksej et al., 2018).